EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Incorporating Molecular Data Into Treatment Decision Making in Gastroesophageal and Pancreaticobiliary Cancers: Timing and Strategies

Andrew Hall, Sarah R Brown, Niharika B Mettu, Paul C Miller, Elizabeth C Smyth, Andrew B Nixon iD

American Society of Clinical Oncology Educational Book · 2024

DOI: 10.1200/edbk_433640 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Society of Clinical Oncology Educational Book, 2024. Verfasst von Andrew Hall und 5 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Cancer Research UK Clinical Trials Unit, University of Leeds, Leeds, United Kingdom. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Molecular Targeted Therapy, Biomarkers, Tumor. Die Arbeit nennt 80 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastroesophageal (GE) and pancreatobiliary (PB) cancers represent a significant clinical challenge. In this context, it is critical to understand the key molecular targets within these malignancies including how they are assayed for as well as the clinical actionability of these targets. Integrating biomarkers into the standard of care presents a critical avenue for refining treatment paradigms. This review aims to explore these complexities, offering insights into the optimal sequencing of chemotherapy and targeted therapies and their utility in the management of GE and PB cancers. The timely integration of promising investigational therapies into clinical practice has broader implications around strategies for future clinical trial designs, which would pave the way for advancements in the management of GE and PB cancers. This review provides guidance in navigating the evolving landscape of GE and PB cancer care, which ultimately will drive forward progress in the field and lead to improved patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsMolecular Targeted TherapyBiomarkers, TumorHumansEsophageal NeoplasmsStomach NeoplasmsClinical Decision-MakingBiliary Tract Neoplasms

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Leeds Cancer Research UK Clinical Trials Unit, University of Leeds, Leeds, United Kingdom.
  • Department of Medicine, Duke University Medical Center, Durham, NC.
  • Oxford NIHR Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom.

ORCID-Profile: Andrew B Nixon

Zitieren

APA

Hall, A., Brown, S. R., Mettu, N. B., Miller, P. C., Smyth, E. C., & Nixon, A. B. (2024). Incorporating Molecular Data Into Treatment Decision Making in Gastroesophageal and Pancreaticobiliary Cancers: Timing and Strategies. American Society of Clinical Oncology Educational Book. https://doi.org/10.1200/edbk_433640

Vancouver

Hall A, Brown SR, Mettu NB, Miller PC, Smyth EC, Nixon AB. Incorporating Molecular Data Into Treatment Decision Making in Gastroesophageal and Pancreaticobiliary Cancers: Timing and Strategies. American Society of Clinical Oncology Educational Book. 2024. doi:10.1200/edbk_433640

BibTeX
@article{Hall2024,
  author = {Hall, Andrew and Brown, Sarah R and Mettu, Niharika B and Miller, Paul C and Smyth, Elizabeth C and Nixon, Andrew B},
  title = {Incorporating Molecular Data Into Treatment Decision Making in Gastroesophageal and Pancreaticobiliary Cancers: Timing and Strategies},
  journal = {American Society of Clinical Oncology Educational Book},
  year = {2024},
  doi = {10.1200/edbk_433640}
}
Kostenlos starten →